LIMITATIONS IN THE USE OF TUBULIN POLYMERIZATION ASSAYS AS A SCREEN FOR THE IDENTIFICATION OF NEW ANTIMITOTIC AGENTS - THE POTENT MARINE NATURAL PRODUCT CURACIN-A AS AN EXAMPLE
E. Hamel et al., LIMITATIONS IN THE USE OF TUBULIN POLYMERIZATION ASSAYS AS A SCREEN FOR THE IDENTIFICATION OF NEW ANTIMITOTIC AGENTS - THE POTENT MARINE NATURAL PRODUCT CURACIN-A AS AN EXAMPLE, Drug development research, 34(2), 1995, pp. 110-120
Curacin A is a newly isolated lipid natural product that binds in the
colchicine site of tubulin and inhibits mitosis. We have examined its
effects on tubulin polymerization, studied by turbidimetry, under thre
e reaction conditions. In 1.0 M glutamate + 1.0 mM MgCl2, with a 37 de
grees C reaction temperature, we could find no concentration of curaci
n A that completely inhibited polymerization. A maximal inhibitory eff
ect on turbidity development (about 50%) was observed with 5 mu M drug
. Higher drug concentrations induced an abnormal polymerization reacti
on, which at 40 mu M differed little from the control reaction except
for slightly delayed depolymerization in response to reducing the temp
erature to 0 degrees C. in 0.8 M glutamate (no MgCl2), with a 30 degre
es C reaction temperature, complete inhibition did occur at 3-5 mu M d
rug, but higher drug concentrations again induced an abnormal polymeri
zation reaction. With 40 mu M curacin A this reaction was also similar
to the control reaction, except that cold-induced depolymerization wa
s slightly enhanced relative to the control. When polymerization was i
nduced by microtubule-associated proteins, maximal inhibition of turbi
dity development (about 70%) occurred with 2 mu M drug, with higher cu
racin A concentrations inducing abnormal polymerization reactions that
reached about 60% of the control turbidity readings. Under all three
reaction conditions the polymer induced by high concentrations of cura
cin A consisted of large aggregates of tightly coiled spiral fibers th
at had a 2-3 filament substructure. The implications of these findings
with curacin A are discussed in terms of the use of tubulin polymeriz
ation assays as a screen for identifying new antimitotic drugs. (C) 19
95 Wiley-Fiss, Inc.